Acute and chronic Graft-versus-host disease after hematopoietic stem cell transplantation
Open Access
- 1 October 2016
- journal article
- review article
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 62 (suppl 1) , 44-50
Abstract
Graft-versus-host disease (GVHD) is one of the main complications of hematopoietic stem cell transplantation, affecting about 50% to 80% of the patients. Acute GVHD and its clinical manifestations are discussed in this article, as well as the new NIH criteria for the diagnosis and classification of chronic GVHD. Therapy for both chronic and acute GVHD is an important field of discussion, as there is no proven superiority for the majority of therapies used after primary treatment has failed. Hence, this review is meant to be a useful consultation tool for hematologists dealing with this complex transplantation procedure complication.Keywords
This publication has 48 references indexed in Scilit:
- Have we improved in preventing and treating acute graft-versus-host disease?Current Opinion in Hematology, 2011
- Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteriaBlood, 2011
- Etanercept, mycophenolate, denileukin, or pentostatin plus corticosteroids for acute graft-versus-host disease: a randomized phase 2 trial from the Blood and Marrow Transplant Clinical Trials NetworkBlood, 2009
- Evaluation of NIH consensus criteria for classification of late acute and chronic GVHDBlood, 2009
- Evaluation of mycophenolate mofetil for initial treatment of chronic graft-versus-host diseaseBlood, 2009
- Graft-versus-host diseaseThe Lancet, 2009
- Therapy with mycophenolate mofetil for refractory acute and chronic GVHDBone Marrow Transplantation, 2009
- Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomesBlood, 2009
- Treatment of Chronic Steroid-Refractory Graft-Versus-Host Disease With Low-Dose RituximabTransplantation, 2008
- How I treat refractory acute GVHDBlood, 2007